Labshake search
Citations for BioLegend :
101 - 150 of 6848 citations for 6 Chloro imidazo 1 2 a pyridine 2 carbaldehyde since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Cell Biology 2020Quote: ... Diamidino-2-Phenylindole (DAPI) (Biolegend) for live/dead exclusion and cell sorting ...
-
bioRxiv - Immunology 2021Quote: ... IL-2 (MQ1-17H12, Biolegend), and IFNγ (4S.B3 ...
-
bioRxiv - Immunology 2021Quote: ... and 2 μM monensin (BioLegend). For intracellular staining of IgM ...
-
bioRxiv - Cancer Biology 2022Quote: ... and monensin (2 μM, Biolegend) in a humidified incubator at 37°C with 5% CO2 ...
-
bioRxiv - Bioengineering 2020Quote: ... beta-2-microglobulin (BioLegend #316306) and Fixable Viability Dye eFluor780 or LIVE/DEAD Fixable Aqua Dead Cell Stain (ThermoFisher #65-0865-14 1:500 dilution ...
-
bioRxiv - Immunology 2022Quote: ... and 2 nM Monensin (BioLegend) were added to each well and incubated for further 2 h ...
-
bioRxiv - Immunology 2019Quote: ... CD138(BV421, 281-2, BioLegend, #142507 ...
-
bioRxiv - Immunology 2020Quote: ... anti-CD138 (281-2, Biolegend), anti-IgD (11-26c.2a ...
-
bioRxiv - Genomics 2021Quote: ... IL-2 (Biolegend, Cat #500310), or CTLA-4 (Biolegend ...
-
bioRxiv - Genomics 2021Quote: ... IL-2 (Biolegend, Cat #500310), or CTLA-4 (Biolegend ...
-
bioRxiv - Immunology 2020Quote: ... 2) huCD45 APC Cy7 (BioLegend), huCD3 PerCp-Cy5.5 (BioLegend) ...
-
bioRxiv - Immunology 2020Quote: ... CD138 (clone 281-2, Biolegend), B220 (clone RA3-6B2 ...
-
bioRxiv - Cancer Biology 2020Quote: ... CD138 (BioLegend; clone: 281-2) and analyzed for germinal center activated B cells (GCB) ...
-
bioRxiv - Immunology 2020Quote: ... IL-2 PE (Biolegend 503808), CD4 PE-Cy7 (Biolegend 100528) ...
-
bioRxiv - Immunology 2020Quote: ... IL-2 BV605 (Biolegend 500332), and Live/dead Near-IR (Invitrogen L10119) ...
-
bioRxiv - Immunology 2021Quote: ... or -BV510 (281-2, Biolegend) and B220-BV421 (RA3-6B2 ...
-
bioRxiv - Immunology 2022Quote: ... CD49d-FITC (R1-2, BioLegend), Tbet-APC (4B10 ...
-
bioRxiv - Pathology 2023Quote: ... CD206 (Biolegend; clone 15-2) and CD163 (Biolegend ...
-
bioRxiv - Cell Biology 2023Quote: ... mouse CD63 (NVG-2, Biolegend), CD9 (312102 ...
-
bioRxiv - Immunology 2023Quote: ... IL-2 (JES6-5H4; Biolegend), TNFa-BV605 (MP6-XT22 ...
-
bioRxiv - Bioengineering 2023Quote: ... IL-2 (BioLegend, Cat. # 500326), and Perforin (BioLegend ...
-
bioRxiv - Cancer Biology 2023Quote: ... and monensin (2 μM, Biolegend) in a humidified incubator at 37°C with 5% CO2 ...
-
bioRxiv - Immunology 2023Quote: ... and CADM1 (2:100, BioLegend) at 37°C for 25 min ...
-
bioRxiv - Immunology 2023Quote: ... anti-CD63 (NVG-2, Biolegend) and anti-XCR1-AF647 (ZET ...
-
bioRxiv - Immunology 2023Quote: ... and CD138 (281-2, BioLegend), while human cells were incubated with CD20 (2H7 ...
-
bioRxiv - Immunology 2024Quote: ... and monensin (2 µM; Biolegend). Phorbol 12-myristate13-acetate (PMA)/ionomycin-stimulated (Cell Activation cocktail ...
-
bioRxiv - Immunology 2023Quote: ... IL-2 secretion was evaluated with the IL-2 assay ELISA kit (Cat#431801, Biolegend). The absorbance value at 450 nm/570 nm was detected by the microplate reader ...
-
bioRxiv - Bioengineering 2023Quote: ... the serum samples collected at 6 hours and 48 hours after administration were diluted 2-fold for ELISA analysis using the LEGEND MAX™ Rat IL-6 ELISA Kit with pre-coated plate (Biolegend, USA) according to the manufacturer’s recommendations with a little modification as described below ...
-
bioRxiv - Immunology 2023Quote: ... IL-4, IL-2, IL-6, IL-10, IL-17A, IL-17F, IL-5, IL-9, IL-13, IL-22; BioLegend Cat# 741044) and Mouse Custom696 Panel (CXCL1(KC) ...
-
bioRxiv - Immunology 2021Quote: ... anti-IgD-FITC (1:20 dilution, clone IA6-2, cat. no. 348206, BioLegend), anti-IgM-FITC (1:20 dilution ...
-
bioRxiv - Microbiology 2021Quote: ... rat anti-mouse CD138-BV605 (clone 281-2, 1:200, Biolegend, cat#142516), rat anti-mouse CD19-BV785 (clone 1D3 ...
-
bioRxiv - Immunology 2024Quote: ... H2-Dd-FITC (1:200; clone 34-2-12; BioLegend Cat. No. 110606), H2-Kd-APC (1:160 ...
-
bioRxiv - Immunology 2021Quote: ... anti-CD138 (clone 281-2, Biolegend). Specific conjugates are indicated within Figures ...
-
bioRxiv - Immunology 2021Quote: ... and Thy1/2 (Biolegend, 30-H12) conjugated to APC-Cy7 each at a concentration of 0.25 μg per 1 x 106 cells to remove dendritic cells ...
-
bioRxiv - Immunology 2021Quote: ... IL-2 (20 ng/ml; BioLegend), IL-4 (20 ng/ml ...
-
bioRxiv - Immunology 2022Quote: ... IL-2 (clone: JES6-5H4; BioLegend) and IL-17A (clone ...
-
bioRxiv - Immunology 2022Quote: ... and Monensin solution (2 μM) (BioLegend). Cells were then stained with one of four antibody panels (Supplementary Table 1 ...
-
bioRxiv - Immunology 2020Quote: ... anti-IL-2-PE-Cy7 (Biolegend) and anti-IL-4-PE (Biolegend) ...
-
bioRxiv - Bioengineering 2021Quote: ... αCD4 mAb (clone RM4-2, Biolegend), anti-Camelid VHH antibody (clone 96A3F5 ...
-
bioRxiv - Bioengineering 2021Quote: ... αCD4 mAb (clone RM4-2, Biolegend), αCD11b mAb (clone M1/70 ...
-
bioRxiv - Immunology 2020Quote: ... α-BCL-2 (BCL/10C4, 633510, Biolegend), α-BIM (K.912.7 ...
-
bioRxiv - Immunology 2020Quote: Panel 2: CD11b-BV421 (Biolegend, 301323), CD274-PE (Biolegend ...
-
bioRxiv - Immunology 2020Quote: ... anti-SDC1-PE (281-2, BioLegend), and anti-FR4-PE Cy7 (ebio12A5 ...
-
bioRxiv - Immunology 2021Quote: ... IgD PE-Cy7 (IA6-2, BioLegend) Zombie NIR (BioLegend ...
-
bioRxiv - Immunology 2021Quote: ... IgD PE-Cy5 (IA6-2, BioLegend), CD14 PerCP (HCD14 ...
-
bioRxiv - Immunology 2022Quote: ... IL-2 BV421 (Biolegend, cat.503826), IL-4 PE (Biolegend ...
-
bioRxiv - Immunology 2022Quote: ... α-CD8b.2 APC (53-5.8, BioLegend) and α-FOXO1 (C29H4 ...
-
bioRxiv - Cancer Biology 2023Quote: ... IL-2 and TNFα kits (BioLegend) and the experiments were done according to the manufacturer’s protocol ...
-
bioRxiv - Immunology 2023Quote: ... 200 IU/ml IL-2 (Biolegend), 12.5% FBS ...
-
bioRxiv - Immunology 2023Quote: ... anti-CD49d (Biolegend, clone: R1-2), anti-NK1.1 (Biolegend ...